Sign inJoin waitlistJoin the waitlist

Keith Heinzerling

HS Associate Clinical Professor · UCLA David Geffen School of Medicine/UCLA Medical Center

Credentials: · · · · ·

History

UCLA David Geffen School of Medicine/UCLA Medical Center
Present

Addiction Medicine
2005–2006
Primary Care Sports Medicine
UCLA David Geffen School of Medicine/UCLA Medical Center
2004–2005
University of California-Los Angeles
University of Minnesota Methodist Hospital
2001–2004
Internal Medicine
NYU Grossman School of Medicine
1998–2001
UCLA Fielding School of Public Health
Stanford University School of Medicine
1994–1998

Research

Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial
JAMA · 2023 · 408 citations
Collaborative Care for Opioid and Alcohol Use Disorders in Primary Care: The SUMMIT Randomized Clinical Trial
JAMA Internal Medicine · 2017 · 184 citations
Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence
Drug and Alcohol Dependence · 2008 · 114 citations

SS
Steven Shoptaw
31 papers
WL
Walter Ling
8 papers
BF
Benjamin Furst
4 papers
Daniel Kelly
4 papers
Allison Diamant
3 papers
James McCracken
3 papers
JT
John Tsuang
3 papers
KL
Karen Lamp
3 papers
Karen Osilla
3 papers
NF
Neil Flynn
3 papers
Steven Asch
3 papers
BK
Benjamin Kelmendi
2 papers

Clinical trials

Study of Pomaglumetad and Methamphetamine
Principal investigator · Terminated · Phase 1
University of California, Los Angeles
2017–2020
Pilot Trial of Bupropion Versus Placebo for Methamphetamine Abuse in Adolescents
Principal investigator · Completed · Phase 2
University of California, Los Angeles
2009–2011
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
Site PI · Recruiting · Phase 3
Cybin IRL Limited
2025–2027